Related Experiment Video
Updated: Oct 23, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
Identifying Nutrition Risk in a Charitable Pharmacy Population
Journal of Health Care for the Poor and Underserved
|August 23, 2021
Summary
A new dual-purpose screening tool identified significant nutrition risk in 63% of patients at a charitable pharmacy. This highlights the need for integrated food insecurity and malnutrition assessments in community health settings.
Area of Science:
- Community Health
- Nutrition Science
- Public Health Policy
Background:
- Food insecurity and malnutrition negatively impact health outcomes and increase healthcare costs.
- Nutrition risk is underassessed in community settings.
- Existing screening tools address food insecurity or malnutrition individually, not concurrently.
Purpose of the Study:
- Implement a dual-purpose screening tool for nutrition risk in a community setting.
- Characterize nutrition risk within a charitable pharmacy population.
- Connect at-risk patients to community nutrition resources.
Main Methods:
- A dual-purpose screening tool was implemented at the Charitable Pharmacy of Central Ohio.
- 221 patients were screened during initial and annual qualification interviews.
- Patients screening positive for nutrition risk were referred to available resources.
Main Results:
- 140 out of 221 (63%) patients screened positive for nutrition risk.
- 84 (38%) screened positive for food insecurity, 14 (6%) for malnutrition risk, and 42 (19%) for both.
- Patients were referred to food pantries, home-delivered meals, and SNAP.
Conclusions:
- A significant portion of patients in a charitable pharmacy setting face nutrition risk.
- A dual-purpose screening tool effectively identifies individuals with food insecurity and/or malnutrition.
- Integrated screening and resource referral are crucial for addressing nutrition risk in community health.
More Related Videos
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
413
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
1.0K
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
473
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
473
01:28Chronic Kidney Disease III: Interprofessional Care
148
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
148
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
40
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
40
01:21Drug Dosing: Obese Patients
30
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
30
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
35
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
35
01:27Nursing Ethical Principles II
1.6K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.6K